Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for Locally Advanced Rectal Cancer：A Randomized Controlled Study (PALACE Study)

NCT07020247 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07020247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for Locally Advanced Rectal Cancer：A Randomized Controlled Study (PALACE Study)
Lead sponsor
West China Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
November 19, 2024
Completion date
January 31, 2028
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal function preservation, immunotherapy, locally advanced rectal cancer (larc), radiotherapy, total neoadjuvant therapy